Esplanade Ventures
Esplanade Ventures is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Esplanade Ventures.
Esplanade Ventures is a company.
Key people at Esplanade Ventures.
Key people at Esplanade Ventures.
Esplanade Ventures is Canada's leading digital health venture capital firm, investing in early-stage and high-growth companies redefining healthcare delivery through technology, particularly AI-enabled solutions impacting patients and professionals.[1][2] Their mission centers on providing capital plus hands-on support—including commercial guidance, GTM strategy, and introductions—while focusing on seed to Series A rounds (selective Series B) in digital health software for North American commercialization, avoiding invasive devices or biotech.[1][3] With over 100 years of collective experience among healthcare operators, founders, and investors, they target key sectors like digital health, AI/ML, healthcare IT, and health & wellness, significantly impacting the startup ecosystem by backing bold ideas that enhance access, efficiency, and outcomes.[1][2]
Headquartered in Montreal with offices in Toronto and Westmount, the firm has made 13 investments, including recent ones like Cerula Care's $3.7M seed in February 2025 and Embr Labs' $3M Series C-II in October 2024, demonstrating active involvement in scaling healthtech innovators.[3]
Esplanade Ventures was founded in 2019 by healthcare veterans, initially formed by the founders of Medisys Health Group and Persistence, two prominent Canadian healthcare companies.[4][5] Key figures include Co-Founder & Chairman Dr. Sheldon Elman (45+ years in healthcare), Co-Founder (20+ years), Managing Partner Ella Seitz (15+ years), Venture Partner Josh Blair (15+ years in healthtech), and Principal Alexandre Nossovskoi (10+ years in VC, innovation, and healthcare).[1][5] The firm's evolution reflects a shift from operational healthcare expertise to venture investing, leveraging a global network across North America, Europe, and Israel to focus on early-stage digital health transforming U.S. and Canadian markets.[1][2]
Esplanade Ventures rides the wave of AI-powered digital health transformation, capitalizing on post-pandemic demand for efficient, accessible care amid rising U.S./Canadian healthcare costs and provider shortages.[1][3] Timing aligns with AI adoption in healthcare IT—projected to grow rapidly—where their operator backgrounds help startups navigate regulatory and commercialization hurdles in North America.[1][2] Market forces like aging populations, telehealth expansion, and AI tools for diagnostics/outcomes favor their portfolio, while they influence the ecosystem by mentoring founders and fostering cross-border (Canada-U.S.-Israel) innovation hubs.[1][3]
Esplanade Ventures is poised to expand its 13-investment portfolio amid surging AI healthtech funding, potentially leading more oversubscribed seeds like Cerula Care while scaling follow-ons into Series B.[3] Trends like AI personalization in care delivery and wearable integration will shape their trajectory, amplifying influence as Canada's top digital health VC bridges operators and innovators.[1][2] Their operator edge positions them to drive outsized ecosystem impact, backing the next wave of healthcare disruptors from Toronto to Tel Aviv.
